Correction to: Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases (Genetics in Medicine, (2017), 19, 2, (224-235), 10.1038/gim.2016.95);Candidate-gene criteria for clinical reporting: Diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases

Genetics in Medicine

Volumn 19, Issue 2, 2017, Pages 224-235

  Hagman, Kelly D Farwell ^a   Shinde, Deepali N ^a   Mroske, Cameron ^a   Smith, Erica ^a   Radtke, Kelly ^a   Shahmirzadi, Layla ^a   El Khechen, Dima ^a   Powis, Zöe ^a   Chao, Elizabeth C ^a,b   Alcaraz, Wendy A ^a   Helbig, Katherine L ^a   Sajan, Samin A ^a   Rossi, Mari ^a   Lu, Hsiao Mei ^a   Huether, Robert ^a   Li, Shuwei ^a   Wu, Sitao ^a   Nuñes, Mark E ^c   Tang, Sha ^a  

^a AMBRY GENETICS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

candidate genes; Clinical diagnostic exome sequencing; gene disease relationships; novel disease genes; novel genetic etiologies

Indexed keywords

ARTICLE; COPY NUMBER VARIATION; DIAGNOSTIC EXOME SEQUENCING; FAMILY HISTORY; GENE DISRUPTION; GENE DUPLICATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; WHOLE EXOME SEQUENCING; EXOME; GENETIC ASSOCIATION STUDY; GENETIC DATABASE; GENETICS; HIGH THROUGHPUT SEQUENCING; MUTATION; PATHOLOGY; PROCEDURES;

DATABASES, GENETIC; EXOME; GENETIC ASSOCIATION STUDIES; GENETIC DISEASES, INBORN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; WHOLE EXOME SEQUENCING;

EID: 85011914769     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2017.263     Document Type: Erratum

References (41)

1. Costa T, Scriver CR, Childs B. The effect of Mendelian disease on human health: a measurement. Am J Med Genet 1985;21:231-242.
2. Dodge JA, Chigladze T, Donadieu J, et al. The importance of rare diseases: from the gene to society. Arch Dis Child 2011;96:791-792.
3. Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 2013;14:681-691.
4. Cooper DN, Chen JM, Ball E V, et al. Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics. Hum Mutat 2010;31:631-655.
5. Stenson PD, Mort M, Ball E V, et al. The Human Gene Mutation Database: 2008 update. Genome Med 2009;1:13.
6. Ku CS, Cooper DN, Polychronakos C, Naidoo N, Wu M, Soong R. Exome sequencing: dual role as a discovery and diagnostic tool. Ann Neurol 2012;71:5-14.
7. Iglesias A, Anyane-Yeboa K, Wynn J, et al. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med 2014;16:922-931.
8. Dixon-Salazar TJ, Silhavy JL, Udpa N, et al. Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med 2012;4:138ra78.
9. Butterfield RJ, Stevenson TJ, Xing L, et al. Congenital lethal motor neuron disease with a novel defect in ribosome biogenesis. Neurology 2014;82: 1322-1330.
10. Rohena L, Neidich J, Truitt Cho M, et al. Mutation in SNAP25 as a novel genetic cause of epilepsy and intellectual disability. Rare Dis 2013;1:e26314.
11. Tuzovic L, Yu L, Zeng W, et al. A human de novo mutation in MYH10 phenocopies the loss of function mutation in mice. Rare Dis 2013;1:e26144.
12. Lalani SR, Zhang J, Schaaf C P, et al. Mutations in PURA cause profound neonatal hypotonia, seizures, and encephalopathy in 5q31.3 microdeletion syndrome. Am J Hum Genet 2014;95:579-583.
13. Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010;42:30-35.
14. Rabbani B, Mahdieh N, Hosomichi K, Nakaoka H, Inoue I. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders. J Hum Genet 2012;57:621-632.
15. Farwell KD, Shahmirzadi L, El-Khechen D, et al. Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genet Med 2015;17:578-586.
16. Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol 2009;27:182-189.
17. LaDuca H, Stuenkel AJ, Dolinsky JS, et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2, 000 patients. Genet Med 2014;16:830-837.
18. Tennessen JA, Bigham AW, O'Connor TD, et al.; Broad GO; Seattle GO; NHLBI Exome Sequencing Project. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012;337:64-69.
19. Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet 2012;13:565-575.
20. Chong JX, Buckingham KJ, Jhangiani SN, et al.; Centers for Mendelian Genomics. The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities. Am J Hum Genet 2015;97:199-215.
21. MacArthur DG, Manolio TA, Dimmock D P, et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014;508:469-476.
22. Lage K, Hansen NT, Karlberg EO, et al. A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci USA 2008;105:20870-20875.
23. Richards S, Aziz N, Bale S, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-424.
24. Speir ML, Zweig AS, Rosenbloom KR, et al. The UCSC Genome Browser database: 2016 update. Nucleic Acids Res 2016;44(D1):D717-D725.
25. Lee H, Deignan JL, Dorrani N, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA 2014;312:1880-1887.
26. Gahl WA, Markello TC, Toro C, et al. The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genet Med 2012;14:51-59.
27. Retterer K, Juusola J, Cho MT, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med 2016;18:696-704.
28. Zhu X, Petrovski S, Xie P, et al. Whole-exome sequencing in undiagnosed genetic diseases: interpreting 119 trios. Genet Med 2015;17:774-781.
29. Srivastava S, Cohen JS, Vernon H, et al. Clinical whole exome sequencing in child neurology practice. Ann Neurol 2014;76:473-483.
30. Yang Y, Muzny DM, Xia F, et al. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 2014;312:1870-1879.
31. Farwell KD, Shahmirzadi L, El-Khechen D, et al. Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genet Med 2015;17:578-586.
32. Worthey EA, Mayer AN, Syverson GD, et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011;13:255-262.
33. Bloss CS, Zeeland AA, Topol SE, et al. A genome sequencing program for novel undiagnosed diseases. Genet Med 2015;17:995-1001.
34. Might M, Wilsey M. The shifting model in clinical diagnostics: how next-generation sequencing and families are altering the way rare diseases are discovered, studied, and treated. Genet Med 2014;16:736-737.
35. Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat 2015;36:928-930.
36. EuroEPINOMICS-RES Consortium; Epilepsy Phenome/Genome Project; Epi4K Consortium. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet 2014;95:360-370.
37. Green ED, Guyer MS; National Human Genome Research Institute. Charting a course for genomic medicine from base pairs to bedside. Nature 2011;470: 204-213.
38. MacArthur DG, Balasubramanian S, Frankish A, et al.; 1000 Genomes Project Consortium. A systematic survey of loss-of-function variants in human protein-coding genes. Science 2012;335:823-828.
39. Reed DR, Lawler MP, Tordoff MG. Reduced body weight is a common effect of gene knockout in mice. BMC Genet 2008;9:4.
40. Zaidi S, Choi M, Wakimoto H, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 2013;498:220-223.
41. Exome Aggregation Consortium; Lek M, Karczewski K, Minikel E, et al. Analysis of protein-coding genetic variation in 60, 706 humans. http://biorxiv.org/content/early/2016/05/10/030338.